Ammonium perfluorooctanoate substantially alters phenotype and cytokine secretion of human monocyte-derived dendritic cells in vitro

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 4, 2009, Pages 641-646

  Ahuja, Varun ^a   Eisenbltter, Martin ^a   Ignatius, Ralf ^a   Stahlmann, Ralf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Ammonium perfluorooctanoate; APFO; Dendritic cells; Perfluoroalkyl carboxylic acid; PFCA

Indexed keywords

CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; PERFLUORO COMPOUND; PERFLUOROOCTANOATE AMMONIUM; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOTOXICITY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; FLUOROCARBONS; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MONOCYTES; OCTANOIC ACIDS;

EID: 70449116509     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970902947317     Document Type: Article

References (25)

1. Guenthner, R.A., Vietor, M.L. Surface active materials from perfluorocarboxylic acid. Ind. Eng. Chem. Prod. Res. Dev. 1962, 1, 165-167.
2. Lau, C., Butenhoff, J.L., Rogers, J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 2004, 198, 231-241.
3. Renner, R. Growing concern over perfluorinated chemicals. Environ. Sci. Technol. 2001, 35, 154A-160A.
4. Banchereau, J., Steinman, R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673), 245-252.
5. MacPherson, G.G. Lymphoid dendritic cells: Their life history and roles in immune responses. Res. Immunol. 1989, 140, 877-926.
6. Clark, G.J., Angel, N., Kato, M., et al. The role of dendritic cells in the innate immune system. Microbes Infect. 2000, 2, 257-272.
7. Lanzavecchia, A., Sallusto, F. Regulation of T cell immunity by dendritic cells. Cell 2001, 106, 263-266.
8. Sallusto, F., Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor -1118.
9. Jonuleit, H., Kühn, U., Müller, G., et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997, 27(12): 3135-3142.
10. Gao, D., Mondal, T.K., Lawrence, D.A. Lead effects on development and function of bone marrow-derived dendritic cells promote Th2 immune responses. Toxicol. Appl. Pharmacol. 2007, 222(1), 69-79.
11. Laupeze, B., Amiot, L., Sparfel, L., et al. Polycyclic aromatic hydrocarbons affect functional differentiation and maturation of human monocyte-derived dendritic cells. J. Immunol. 2002, 168, 2652-2658.
12. Hymery, N., Sibiril, Y., Parent-Massin, D. In vitro effects of trichothecenes on human dendritic cells. Toxicol. in Vitro 2006, 20, 899-909.
13. Vorderstrasse, B.A., Dearstyne, E.A., Kerkvliet, N.I. Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antigenpresenting activity of dendritic cells. Toxicol. Sci. 2003, 72, 103-112.
14. Sanderson, J.P., Naisbitt, D.J., Farrell, J., et al. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J. Immunol. 2007, 178, 5533-5542.
15. Ryan, C.A., Gerberick, G.F., Gildea, L.A., et al. Interactions of contact allergens with dendritic cells: Opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol. Sci. 2005, 88, 4-11.
16. Schreiner, M., Peiser, M., Briechle, D., et al. A new dendritic cell type suitable as sentinel of contact allergens. Toxicology 2008, 249: 146-152.
17. Verhasselt, V., Buelens, C., Willems, F., et al. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway. J. Immunol. 1997, 158(6), 2919-2925.
18. Zhou, L.J., Tedder, T.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 1995, 154(8), 3821-3835.
19. Jasny, E., Eisenblätter, M., Mätz-Rensing, K., et al. IL-12- impaired and IL-12-secreting dendritic cells produce IL-23 upon CD154 restimulation. J. Immunol. 2008, 180, 6629-6639.
20. Abate, G., Eslick, J., Newman, F.K., et al. Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T-cells capable of antigen-specific expansion and effector functions. J. Infect. Dis. 2005, 192(8), 1362-1371.
21. Hulette, B.C., Ryan, C.A., Gildea, L.A., Gerberick, G.F. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicol. Appl. Pharmacol. 2005, 209, 159-166.
22. Matzinger, P. The danger model: A renewed sense of self. Science 2002, 296, 301-305.
23. Pepin, E., Goutet, M., Ban, M. Murine bone marrow-derived dendritic cells as a potential in vitro model for predictive identification of chemical sensitizers. Toxicol. Lett. 2007, 175, 89-101.
24. Jugde, F., Boissier, C., Rougier-Larzat, N., et al. Regulation by allergens of chemokine receptor expression on in vitro-generated dendritic cells. Toxicology 2005, 212, 227-238.
25. Jonuleit, H., Kühn, U., Müller, G., et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997, 27(12), 3135-3142.